Degludec hospital trial: A randomized controlled trial comparing insulin degludec U100 and glargine U100 for the inpatient management of patients with type 2 diabetes.

Rodolfo J GalindoFrancisco J PasquelPriyathama Vellanki Radica Z Alicic David W LamMaya FayfmanAlexandra L MigdalGeorgia M DavisSaumeth CardonaMaria A UrrutiaCitlalli Perez-GuzmanKarla Walkiria Zamudio-CoronadoLimin PengKatherine R Tuttle Guillermo E Umpierrez

Published in: Diabetes, obesity & metabolism (2021)

Hospital treatment with degludec-U100 or glargine-U100 is equally safe and effective for the management of hyperglycaemia in general medical and surgical patients with type 2 diabetes.

Keyphrases

healthcare
acute care
glycemic control
type diabetes
mental health
palliative care
adverse drug
phase ii
replacement therapy